ORG Wealth Partners
BBNX icon

ORG Wealth Partners’s Beta Bionics BBNX Stock Holding History

ORG Wealth Partners’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$284 Buy
+15
New +$269 ﹤0.01% 2266

Other funds holding BBNX

JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $33.4B AUM 56.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
ING Group
ING Group Amsterdam, Netherlands $17.7B AUM 39.02% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $100B AUM 26.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

ORG Wealth Partners's BBNX Position: Q3 2026 in Review

ORG Wealth Partners opened a new position in Beta Bionics (BBNX) in Q3 2026: 15 shares worth $284. The stake represents ﹤0.01% of the portfolio and ranks #2266 among its holdings.

84 funds tracked by Wall St. Rank hold BBNX as of Q3 2026.

  • ORG Wealth Partners held 15 shares of Beta Bionics worth $284 as of Q3 2026.
  • Beta Bionics was a new ORG Wealth Partners position in Q3 2026.
  • Beta Bionics made up ﹤0.01% of ORG Wealth Partners's portfolio in Q3 2026, its #2266 holding.
  • 84 funds tracked by Wall St. Rank held Beta Bionics as of Q3 2026.

Based on ORG Wealth Partners's 13F filing for Q3 2026, filed 3 Nov 2026.